|
|
| Médicaments En Vente Libre > Etude de marché sectorielle |
| OTC healthcare in Indonesia to 2009 |
|
|
|
|
€ 420,75 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Novembre 2005 |
Taille du document : |
129 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
US Gastrointestinal Remedies 2004
12 pages | Novembre 2004 |
Snapdata's US Gastrointestinal Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US gastrointestinal |
240,00 €
|
| |
| |
US Antacids 2004
16 pages | Juillet 2004 |
Snapdata's US Antacids 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US antacid market, and covers antacid |
240,00 €
|
| |
| |
US Lip Remedies 2004
13 pages | Juillet 2004 |
Snapdata's US Lip Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US lip remedy market, and covers |
240,00 €
|
| |
| |
US Acne Treatments 2004
14 pages | Juillet 2004 |
Snapdata's US Acne Treatments 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US acne treatments market.
|
240,00 €
|
| |
| |
US External Analgesics 2004
16 pages | Juillet 2004 |
Snapdata's US External Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US external analgesic mark |
240,00 €
|
| |
| |
US Laxatives 2004
12 pages | Novembre 2004 |
Snapdata's US Laxatives 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US laxative market, and covers laxat |
240,00 €
|
| |
| |
US Smoking Cessation Aids 2004
13 pages | Juillet 2004 |
Snapdata's US Smoking Cessation Aids 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US smoking cessation ai |
240,00 €
|
| |
| |
The Biogenerics Market Outlook: An analysis of market dynamics, growth drivers and leading players
87 pages | Mars 2005 |
Branded biologic medicines generated an estimated $32bn of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of medicines; while continued high demand |
2 443,75 €
|
| |
| |
Generics Defense Strategies: Effective brand protection through patent, formulation, OTC and DTC strategies
146 pages | Janvier 2005 |
Pressure on the pharmaceutical industry to deliver productivity, strong generics market growth as well as an unfavorable legislative environment have caused pharmaceutical companies to reassess the mo |
2 443,75 €
|
| |
| |
US Vitamins & Minerals 2004
13 pages | Novembre 2004 |
Snapdata's US Vitamins & Minerals 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US vitamin and mineral mar |
240,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| OTC healthcare in Indonesia to 2009 |
|
|
Introduction
This databook is a detailed information resource covering all the key data points on OTC Healthcare in Indonesia. It includes comprehensive value, segmentation and market share data. The databook supplies actual data to 2004 and full forecasts to 2009.
Scope
Contains information on seven categories including: Analgesics, Cough & Cold preparations, Indigestion preparations and Other OTC healthcare products.
Provides market value and expenditure data by market, segment and subsegment.
Includes company data by category, as well as distribution channel data.
Contains market value segmentation by demographic and socioeconomic group.
Highlights
The market for OTC healthcare in Indonesia increased between 1999-2004, growing at an average annual rate of 7.5%.
The leading company in the market in 2004 was Bayer AG. The second-largest player was Blackmores, with GlaxoSmithKline Plc in third place.
Reasons to Purchase
Discover the major quantitative trends affecting the OTC healthcare market.
Understand consumers' consumption and expenditure patterns.
Understand the future direction of the market with reliable historical data and full five year forecasting.
|
|
Introduction
This databook is a detailed information resource covering all the key data points on OTC Healthcare in Indonesia. It includes comprehensive value, segmentation and market share data. The databook supplies actual data to 2004 and full forecasts to 2009.
Scope
Contains information on seven categories including: Analgesics, Cough & Cold preparations, Indigestion preparations and Other OTC healthcare products.
Provides market value and expenditure data by market, segment and subsegment.
Includes company data by category, as well as distribution channel data.
Contains market value segmentation by demographic and socioeconomic group.
Highlights
The market for OTC healthcare in Indonesia increased between 1999-2004, growing at an average annual rate of 7.5%.
The leading company in the market in 2004 was Bayer AG. The second-largest player was Blackmores, with GlaxoSmithKline Plc in third place.
Reasons to Purchase
Discover the major quantitative trends affecting the OTC healthcare market.
Understand consumers' consumption and expenditure patterns.
Understand the future direction of the market with reliable historical data and full five year forecasting.
|
|
|
PPLSEN
|
|
|
|
|
